Spyglass Pharma Inc stock is traded at $34.08, with a volume of 192,281. It is down -1.07% in the last 24 hours and up +33.18% over the past month. SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
Previous Close:
$34.45
Open:
$34.61
24h Volume:
192,281
Relative Volume:
1.43
Market Cap:
$1.14B
Revenue:
-
Net Income/Loss:
-$43.60M
P/E Ratio:
-
EPS:
-$5.29
Net Cash Flow:
-
1W Performance:
+4.83%
1M Performance:
+33.18%
6M Performance:
+39.61%
1Y Performance:
0.00%
1-Day Range:
$32.00$34.61
1-Week Range:
$31.60$35.75
52-Week Range:
$17.06$35.75
Spyglass Pharma Inc Stock (SGP) Company Profile
Name
Spyglass Pharma IncSector
HealthcareIndustry
BiotechnologyPhone
949-284-6904Address
27081 ALISO CREEK ROAD, ALISO VIEJO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS